Dr. Allan Jordan

Sygnature Discovery

Dr. Allan Jordan Explores the Use of Acoustic Liquid Handling in Cancer Drug Discovery

Dr. Allan Jordan, Head of Chemistry at the Drug Discovery Unit, Cancer Research UK Manchester Institute, describes how the institute is translating research into new cancer treatments. Jordan explains how he explores new, potential compounds capable of interfering with cancer cells as a start-point for targeted and personalized cancer therapies. Jordan utilizes acoustic liquid dispensing to dose reduced volumes of compounds to be investigated, enabling a higher quality and quantity of data to be produced, and so accelerating his research.



LIKE 0


Dr. Allan Jordan
Cancer Research Cell Analysis

Dr. Allan Jordan

Biography

Allan Jordan is Director of Oncology Drug Discovery at Sygnature Discovery. More
Follow Allan

Dr. Allan Jordan

Sygnature Discovery

Allan Jordan is Director of Oncology Drug Discovery at Sygnature Discovery.